首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
首頁 > 市場調查報告書 > 製藥 > 糖尿病 > 糖尿病與懷孕
產業/市場分類
製藥 (4495)
肥胖症治療 (48)
非專利藥 (117)
疫苗 (168)
神經疾病 (175)
骨頭疾病治療 (41)
動物用醫藥 (18)
處方藥 (89)
規章 (107)
感染疾病 (318)
精神病 (80)
製藥企業 (506)
糖尿病 (157)
癌症 (838)
藥物開發 (1275)
DDS (173)
OTC 非處方藥 (147)
市場調查報告書

糖尿病與懷孕

Diabetes and Pregnancy - Delivering Improved Outcomes

出版商 Datamonitor
出版日期 2004年06月 商品編碼 20753
內容資訊 英文  
價格
本報告書已不再販售

本報告已在2011年07月19日停止出版。

簡介

糖尿病可能會對懷孕中的女性帶來風險,反過來說,醫療技術的進步相對的也大幅提升了孕婦的健康狀況。然而,不接受治療,也就是健康管理不佳造成的妊娠糖尿病,其嚴重的後果甚至可能會危及胎兒。

專門從事多種市場調查分析的英國調查公司 Datamonitor Corporation〈總公司:倫敦〉,針對妊娠糖尿病以及之前就患有糖尿病的孕婦進行 調查、分析,並出版報告書 "Diabetes and Pregnancy - Delivering Improved Outcomes"

該報告書中,重新檢討患有妊娠糖尿病的母親以及之前就換有糖尿病的孕婦以及胎兒的健康,並且對以往進行的療程方面也做了深度的檢討,大量刊載了篩選與診斷指導原則的概要。本報告書包含 10 張圖表 ,共有 30 頁,概略如下所記。

摘要

  • 說明
  • 調查範圍
  • 主要結果

妊娠糖尿病〈GDM〉

  • 定義
  • 篩選與診斷
  • 發生率
  • 病態生理學
    • 母親
    • 胎兒
  • GDM 的管理
    • 分娩前管理
    • 婦產科的管理
    • 懷孕後的管理

懷孕的糖尿病患者的健康管理

  • 懷孕前的新陳代謝調節與先天性畸形
  • 沒有併發症的糖尿病孕婦之健康管理
    • 營養方面的建言
    • 運動
    • 胰島素
  • 含有血管併發症之糖尿病孕婦的健康管理
    • 冠狀動脈疾病
    • 糖尿病腎臟病變
    • 糖尿病視網膜症

附錄

  • 參考文獻

目錄

Introduction

About one in 100 women of childbearing age have diabetes before pregnancy (pre-existing diabetes). Another 3-5% develop diabetes during pregnancy (gestational diabetes). While diabetes poses some risks in pregnancy, advances in healthcare have greatly improved the outlook for these pregnancies. However, untreated or poorly controlled gestational diabetes can seriously harm the fetus.

Scope of this report

  • Review of therapeutic approaches to gestational diabetes mellitus and pre-existing diabetes during pregnancy to protect the health of mother & baby
  • Overview of screening and diagnosis guidelines

Research and analysis highlights

The prevalence of congenital anomalies among children of diabetic women is much higher compared to non-diabetic women. The frequency of malformations correlates with the degree of maternal glycemic control. Their prevalence may be reduced by normalization of blood glucose and the maintenance of normal glycemic control throughout the pregnancy.

Key reasons to read this report

  • Get insight in the current therapeutic approaches used to treat women with gestational and pre-existing diabetes during pregnancy
  • Understand the effect of diabetes in pregnancy outcomes and gauge the impact of diabetic complications in the treatment of pregnant women

ABOUT DATAMONITOR HEALTHCARE

About the Cardiovascular pharmaceutical analysis team

EXECUTIVE SUMMARY

Introduction
Scope and coverage of the Brief
Key findings about the topic

GESTATIONAL DIABETES MELLITUS

Definition
Screening and diagnosis
Prevalence
Pathophysiology
The mother
The fetus
Management of GDM
Antepartum management
Nutrition therapy
Monitoring effectiveness of therapy
Intensification of treatment
Obstetric management
Assessment of fetal wellbeing
Timing and mode of delivery
Management after pregnancy
The mother
The child

MANAGEMENT OF PREGNANT DIABETICS

Preconceptional metabolic control and congenital malformations
Management of pregnant diabetic women without complications
Nutrition recommendations
Exercise
Insulin
Hypoglycemia
Ketosis
Management of pregnant diabetic women with vascular complications
Coronary artery disease
Diabetic nephropathy
Retinopathy

APPENDIX

Bibliography
Disclaimer

List of Tables

Table 1: Diagnostic criteria for GDM
Table 2: Glucose targets for antepartum management of GDM
Table 3: Estimated prevalence of CAD in diabetics in the seven major markets, 2003
Table 4: Estimated prevalence of diabetic nephropathy in the seven major markets, 2003
Table 5: Changes in kidney structure and function in diabetic nephropathy
Table 6: Perinatal outcome of patients with diabetic nephropathy
Table 7: Estimated prevalence of diabetic retinopathy in the seven major markets, 2003

List of Figures

Figure 1: Classification of patients at risk of developing GDM
Figure 2: Recommended screening for patients at risk of developing GDM
Figure 3: White's classification of diabetes in pregnancy
Back to Top